Symptom patterns in late luteal-phase dysphoric disorder

1992 ◽  
Vol 14 (2) ◽  
pp. 189-199 ◽  
Author(s):  
Ana D. Rivera-Tovar ◽  
Paul Pilkonis ◽  
Ellen Frank
Keyword(s):  
Luteal Phase ◽  
Late Luteal Phase ◽  
Symptom Patterns

scholarly journals Luteotrophic effects of relaxin, chorionic gonadotrophin and FSH in common marmoset monkeys (Callithrix jacchus)

Reproduction ◽  
2010 ◽  
Vol 139 (5) ◽  
pp. 923-930 ◽  
Author(s):  
Nicola Beindorff ◽  
Almuth Einspanier
Keyword(s):  
Early Pregnancy ◽  
Luteal Phase ◽  
Common Marmoset ◽  
Chorionic Gonadotrophin ◽  
Traditional Role ◽  
Local Effects ◽  
Ringer’S Solution ◽  
Late Luteal Phase ◽  
Marmoset Monkeys

In early pregnant primates, relaxin (RLX) is highly upregulated within the corpus luteum (CL), suggesting that RLX may have an important role in the implantation of the blastocyst. Therefore, the aim of the present study was to investigate the local effects of RLX and gonadotrophins on the maintenance of the CL using anin vitromicrodialysis system. CLs of common marmoset monkeys were collected by luteectomy during different stages of the luteal phase and early pregnancy. Each CL was perfused with either Ringer's solution alone or Ringer's solution supplemented with either porcine RLX (250, 500 and 1000 ng/ml) or gonadotrophins (50 IU/ml). Application of RLX provoked a significant luteal response of progesterone (P4) and oestradiol (E2) secretions during the mid-luteal phase (500 ng/ml: P454±42%, E224±11%; 1000 ng/ml: E216±13%), and especially during the late luteal phase (250 ng/ml: P453±10%; 500 ng/ml: P444±15%; 1000 ng/ml: P462±15%, E218±7%). The effects of RLX on steroid secretion were irrespective of the RLX dosages. While treatment with human chorionic gonadotrophin did not affect luteal steroid or RLX secretion, the application of FSH resulted in a significant increase in the secretion of both P4(20±8%) and E2(37±28%), and a prominent rise in RLX during early pregnancy. In conclusion, our results demonstrate that RLX and FSH have a luteotrophic function in the marmoset monkeys; moreover, FSH has a function beyond its traditional role just as a follicle-stimulating hormone.

STIMULATION BY HUMAN CHORIONIC GONADOTROPHIN OF OESTRADIOL PRODUCTION BY DISPERSED CELLS FROM HUMAN CORPUS LUTEUM: COMPARISON WITH PROGESTERONE PRODUCTION; UTILIZATION OF EXOGENOUS TESTOSTERONE

1981 ◽  
Vol 91 (2) ◽  
pp. 197-203 ◽  
Author(s):  
M. C. RICHARDSON ◽  
G. M. MASSON
Keyword(s):  
Luteal Phase ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Cell Suspensions ◽  
Corpora Lutea ◽  
Progesterone Production ◽  
Late Luteal Phase ◽  
Oestradiol Production ◽  
Dispersed Cells

Cell suspensions were prepared from tissue samples of human corpora lutea obtained during the mid- and late-luteal phase of the menstrual cycle. Both oestradiol and progesterone production by dispersed cells were stimulated by similar concentrations of human chorionic gonadotrophin (hCG). As the degree of stimulation of production by hCG was greater for progesterone than for oestradiol (five- to tenfold compared with two- to threefold higher than basal production), the ratio of progesterone to oestradiol produced varied according to the level of trophic stimulation. A comparison of cell suspensions prepared from mid- and late-luteal phase corpora lutea, exposed to the same concentration of hCG (10 i.u./ml) in vitro, did not reveal a shift to oestradiol production in the late-luteal phase. Provision of additional testosterone during incubation raised the level of oestradiol production by dispersed luteal cells. At an optimum concentration of testosterone (1 μmol/l), oestradiol synthesis was not raised further in the presence of hCG or N6, O2-dibutyryl cyclic AMP, suggesting a lack of induction or activation of the aromatase system by gonadotrophin in short-term cultures. Basal and stimulated levels of progesterone production were not significantly impaired in the presence of testosterone.

Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder

1994 ◽  
Vol 36 (3) ◽  
pp. 201-202 ◽  
Author(s):  
Donna E. Stewart ◽  
Margaret Fairman ◽  
Sandra Barbadoro ◽  
Patricia Zownir ◽  
Meir Steiner
Keyword(s):  
Luteal Phase ◽  
Late Luteal Phase

Noninvasive evaluation of cardiovascular hemodynamics during multiple follicular stimulation, late luteal phase and early pregnancy

1989 ◽  
Vol 51 (5) ◽  
pp. 796-802 ◽  
Author(s):  
Giovanni B. La Sala ◽  
Oscar Gaddi ◽  
Gabriele Bruno ◽  
Loris Brandi ◽  
Milva Cantarelli ◽  
...  
Keyword(s):  
Early Pregnancy ◽  
Luteal Phase ◽  
Noninvasive Evaluation ◽  
Cardiovascular Hemodynamics ◽  
Late Luteal Phase ◽  
Follicular Stimulation

Altered Serotonergic Activity in Women with Dysphoric Premenstrual Syndromes

1993 ◽  
Vol 23 (1) ◽  
pp. 1-27 ◽  
Author(s):  
Uriel Halbreich ◽  
Henry Tworek
Keyword(s):  
Treatment Outcome ◽  
Menstrual Cycle ◽  
Luteal Phase ◽  
Symptomatic Treatment ◽  
Gonadal Hormones ◽  
Interactive System ◽  
Library Search ◽  
Serotonergic Activity ◽  
Late Luteal Phase

Objective: Dysphoric Premenstrual Syndromes (PMS) are quite prevalent and in some women they are severe enough to warrant treatment. Their pathophysiology is still unknown, despite increased interest and research. Here we review the possible role of serotonin in the multidimensional interactive pathophysiology of PMS. Method: Over 170 articles are reviewed. An extensive library search has been conducted and articles are included because of their relevance to: 1) the phenomenology of PMS; 2) the putative association of serotonergic (5-HT) activity with syndromes that occur premenstrually; 3) changes in 5-HT activity along the menstrual cycle, especially the late luteal phase; 4) influence of gonadal hormones on serotonergic functions; 5) endocrine strategies for assessment of 5-HT abnormalities; and 6) treatment studies of PMS with serotonergic agonists. Results and Conclusions: The data presented here suggest that post-synaptic serotonergic responsivity might be altered during the late-luteal-premenstrual phase of the menstrual cycle. Some serotonergic functions of women with PMS might be altered during the entire cycle and be associated with a vulnerability trait. It is hypothesized that gonadal hormones might cause changes in levels of activity of 5-HT systems as part of a multidimensional interactive system. Strategies to evaluate 5-HT activities in the context of the menstrual cycle are discussed—leading to the conclusion that the most promising approach is active stimulation with specific post-synaptic serotonin agonists. Treatment outcome studies of some imperfect compounds that are currently applied as a symptomatic treatment of PMS support the notion that 5-HT is involved in the pathophysiology of these syndromes.

scholarly journals Evidence for a PGF2α auto-amplification system in the endometrium in mares

Reproduction ◽  
2016 ◽  
Vol 151 (5) ◽  
pp. 517-526 ◽  
Author(s):  
Keisuke Kozai ◽  
Shota Tokuyama ◽  
Anna Z Szóstek ◽  
Yuko Toishi ◽  
Nobuo Tsunoda ◽  
...  
Keyword(s):  
Mrna Expression ◽  
Stromal Cells ◽  
Luteal Phase ◽  
Endometrial Cell ◽  
Late Luteal Phase ◽  
Prostaglandin F ◽  
Amplification System ◽  
Prostaglandin Endoperoxide Synthase

AbstractIn mares, prostaglandin F2α(PGF2α) secreted from the endometrium is a major luteolysin. Some domestic animals have an auto-amplification system in which PGF2αcan stimulate its own production. Here, we investigated whether this is also the case in mares. In anin vivostudy, mares at the mid-luteal phase (days 6–8 of estrous cycle) were injected i.m. with cloprostenol (250 µg) and blood samples were collected at fixed intervals until 72 h after treatment. Progesterone (P4) concentrations started decreasing 45 min after the injection and continued to decrease up to 24 h (P < 0.05). In turn, 13,14-dihydro-15-keto-PGF2α(PGFM) metabolite started to increase 4h after an injection and continued to increase up to 72 h (P < 0.05). PGF receptor (PTGFR) mRNA expression in the endometrium was significantly higher in the late luteal phase than in the early and regressed luteal phases (P < 0.05).In vitro, PGF2αsignificantly stimulated (P < 0.05) PGF2αproduction by endometrial tissues and endometrial epithelial and stromal cells and significantly increased (P < 0.05) the mRNA expression of prostaglandin-endoperoxide synthase-2 (PTGS2), an enzyme involved in PGF2αsynthesis in endometrial cell. These findings strongly suggest the existence of an endometrial PGF2αauto-amplification system in mares.

Characterizing Women Who Seek Treatment for Late Luteal Phase Dysphoric Disorder (LLPDD)

1992 ◽  
Vol 1 (4) ◽  
pp. 301-305 ◽  
Author(s):  
STACEY STEINBERG NYE ◽  
STEPHEN W. HURT ◽  
SALLY K. SEVERINO ◽  
GARY A. SHANGOLD
Keyword(s):  
Luteal Phase ◽  
Late Luteal Phase
Sign in / Sign up

Export Citation Format

Share Document